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Most evidence for interpregnancy interval (IPI) and adverse birth outcomes come from stud-
ies that are prone to incomplete control for confounders that vary between women. Compar-
ing pregnancies to the same women can address this issue.
Methods
We conducted an international longitudinal cohort study of 5,521,211 births to 3,849,193
women from Australia (1980–2016), Finland (1987–2017), Norway (1980–2016) and the
United States (California) (1991–2012). IPI was calculated based on the time difference
between two dates—the date of birth of the first pregnancy and the date of conception of the
next (index) pregnancy. We estimated associations between IPI and preterm birth (PTB),
spontaneous PTB, and small-for-gestational age births (SGA) using logistic regression
(between-women analyses). We also used conditional logistic regression comparing IPIs
and birth outcomes in the same women (within-women analyses). Random effects meta-
analysis was used to calculate pooled adjusted odds ratios (aOR).
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Results
Compared to an IPI of 18–23 months, there was insufficient evidence for an association
between IPI <6 months and overall PTB (aOR 1.08, 95% CI 0.99–1.18) and SGA (aOR
0.99, 95% CI 0.81–1.19), but increased odds of spontaneous PTB (aOR 1.38, 95% CI 1.21–
1.57) in the within-women analysis. We observed elevated odds of all birth outcomes asso-
ciated with IPI�60 months. In comparison, between-women analyses showed elevated
odds of adverse birth outcomes for <12 month and >24 month IPIs.
Conclusions
We found consistently elevated odds of adverse birth outcomes following long IPIs. IPI
shorter than 6 months were associated with elevated risk of spontaneous PTB, but there
was insufficient evidence for increased risk of other adverse birth outcomes. Current recom-
mendations of waiting at least 24 months to conceive after a previous pregnancy, may be
unnecessarily long in high-income countries.
Introduction
Both short and long interpregnancy intervals (IPI) have been associated with increased risk of
adverse birth outcomes such as preterm birth (PTB, < 37 weeks of gestation) [1–6], small-for-
gestational age (SGA) [7–9] and term low birth weight (LBW) [4, 10, 11], among other adverse
perinatal outcomes [12–16]. Meta-analyses have reported that short (<6 months) and long
(�60 months) IPIs are associated with increased risk of PTB, SGA, term LBW compared to an
IPI of 18–23 months [17]. In 2005, the World Health Organization recommended waiting at
least 24 months before attempting pregnancy following a live birth [18]. This was based on
limited evidence and analyses based on studies available at the time, mostly from low- and
middle-income countries.
Although adverse effects of IPIs have been consistently reported for between-women
(unmatched) cohort studies, results from more recent within-women (matched) studies
that compare different pregnancies from the same women suggest bias in the between-
women studies, due to unmeasured or inadequately controlled maternal characteristics that
remain stable between pregnancies [19–22]. The first study of this type was conducted by
Ball et al. [20] in Western Australia and reported that the increased risk of PTB, term LBW
and SGA after a short IPI was lower when comparing subsequent pregnancies to the same
women. Swedish [22] and Californian [23] studies have since reported substantially smaller
associations between short intervals and adverse birth outcomes when using such a within-
women design [22, 23]. A Canadian study comparing outcomes of pregnancies within the
same women reported that short IPIs were associated with reduced, not increased odds of
PTB [21]. A systematic review also indicated that results for the associations between IPI
and adverse births outcomes were inconsistent [24]. Therefore, the direction and magni-
tude of the association between short intervals and adverse birth outcomes remains
unclear.
We conducted an international longitudinal cohort study to investigate the association
between IPI and adverse birth outcomes in four high-income countries, using within-women
and between-women analyses.
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Methods
Study design and population
We conducted an international longitudinal cohort study on the association between IPI and
birth outcomes using individual-level perinatal records from four high-income countries: Aus-
tralia (Western Australia [WA] and New South Wales [NSW]) (1980–2016), Finland (1987–
2017), Norway (1980–2016), and the United States (California) (1991–2012). Descriptions of
the perinatal data sources are described in the published protocol [25]. In summary, perinatal
records of birth with complete or near-complete coverage were obtained from the Midwives
Notifications System (WA), the Perinatal Data Collection (NSW), the Medical Birth Register
of Finland, and the Medical Birth Register of Norway. For California, we obtained a linked
birth cohort file that merged fetal death, birth, and infant death certificates provided by the
Office of Statewide Health Planning and Development (OSHPD) [25]. These data sources con-
tain unique identifiers for women and births that allow linkage of births to their mothers. We
followed the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) checklist to report our findings [26] (S1 Checklist).
Inclusion criteria
There were 11,383,557 births from the participating countries/states during the study period,
1980 to 2017 (Australia: 3,074,232; Finland: 1,850,446; Norway: 2,094,171; California:
4,364,708). We excluded birth records for multiple gestations, with gestational age <22 or >44
weeks, with missing birth weight or weight <500g, with unspecified sex, and records with
missing maternal age or age<14 years at birth [25]. These exclusions resulted in 9,902,167
births, and of these we excluded records without prior registered births (i.e. no IPI), leaving
5,521,206 births to 3,849,191 women for the between-women analyses (S1 Fig). Finally, we
identified births to women with at least two or more IPIs resulting in a cohort of 2,905,703
births to 1,233,688 women for within-women analyses. Study entry was defined for all women
as the earliest birth during the study period with an IPI.
Outcomes
We investigated three birth outcomes: PTB, spontaneous PTB and SGA. PTB was defined as
birth<37 completed weeks of gestation. For most countries, spontaneous PTB was defined as
PTB with spontaneous onset of labour, while for California, spontaneous PTB was defined as a
PTB with any of the following three criteria: premature rupture of membranes, premature
labour or tocolysis. SGA was defined as a birthweight in the lowest 10th centile based on the
national birthweight distributions in each country by final week of gestational age and sex.
Exposure
IPI was the main exposure and calculated based on the time difference between two dates—the
date of birth of the first pregnancy and the date of conception of the next (index) pregnancy
(birth date minus gestational length) [27]. In all countries, ultrasound was routinely used to
confirm gestational age and where unavailable it was calculated based on the date of the men-
strual period. IPI was categorised as: 0–5, 6–11, 12–17, 18–23, 24–59, 60–119, and�120
months, with 18–23 months used as the reference category [20].
Statistical analyses
All analyses were adjusted using a prognostic score derived with logistic regression of the birth
outcome regressed on time-varying covariates. Prognostic score adjustment [28, 29] was
PLOS ONE Interpregnancy intervals and adverse birth outcomes
PLOS ONE | https://doi.org/10.1371/journal.pone.0255000 July 19, 2021 3 / 17
adopted to minimise the within-women collinearity between the exposure and the time-vary-
ing adjustment variables. The variables included when creating prognostic score were mater-
nal age (<20, 20–24, 25–29, 30–34, 35–39, and�40 years), parity (1, 2, 3,�4) and year of birth
(5-year categories). We also assessed sensitivity to (i) inclusion of stillbirths in the IPI defini-
tions [30, 31]; (ii) between-women analyses for women with at least two IPIs (at least three
births); and (iii) additional adjustment for socioeconomic status (SES) for the cohorts with this
information available: Australia, Finland, and California. For Australia, SES was derived based
on scores from the Index of Relative Socio-Economic Disadvantage (quintiles), a composite of
education, skilled occupation status, and household income [32]. For Finland, SES was
recorded using maternal occupational status at the time of birth and included four categories
(blue collar, lower-white collar, upper-white collar workers, and ‘other’). For California,
maternal educational attainment was considered as a proxy measure of SES and comprised
four categories (some high school or less, high school diploma/equivalent, some college, col-
lege graduate or more). SES adjustment was not possible for Norway for which no SES infor-
mation was available. Furthermore, we conducted additional analyses to assess sensitivity of
our results for the inclusion of births of from higher-order parity women by restricting our
cohort to the first three births (parity 0, 1 and 2) in Australia and Norway and for the inclusion
of births with gestational ages estimated using LMP by restricting births from 1990 onwards in
Norway when ultrasound is being widely used to estimate gestational ages.
Conventional logistic regression was used for between-women analyses and conditional
logistic regression applied for within-women analyses that compared the outcomes and expo-
sures of subsequent pregnancies to the same women. First, analyses were conducted for each
country and each outcome measure separately. Second, country-specific adjusted odds ratios
(aOR) for the between-women and within-women analyses were pooled using the inverse vari-
ance method with random intercepts for country [33]. Heterogeneity in the estimates between
countries was identified with the I2 statistic [34]. Analyses were done with SAS version 9.4 and
Stata version 14.
Ethical statement
Ethics approval was obtained from Human Research Ethics Committees and Institutional Review
Boards from the Departments of Health in Western Australia and New South Wales, Curtin Uni-
versity, Stanford University, and the Norwegian Regional Committees for Medical and Health
Research Ethics of South/East Norway. Each committee provided a waiver of consent for use of par-
ticipants’ data. For Finland, ethical approval was not required for studies based on registry data.
Results
Cohort characteristics at study entry
Approximately 89–93% of women entered the study cohort at parity 1 in Australia, Finland,
Norway, and 98% in California for the within-women study (Table 1). For the between-
women study, except in California, 87–90% of women entered the study cohort at parity 1 (S1
Table). In the within-women study, at study entry, the highest proportion of women were
between the ages of 25 and 29 years in Australia (36%), Finland (43%), and Norway (45%); but
were between 20 and 24 years in California (35%).
Country specific analysis
We observed that 6.7% of all births had IPI<6 months, ranging from 3.8% of births in Norway
to 7.9% in California (Table 2). The proportion of births after an IPI of 18–23 months was
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similar across countries ranging from 12.9% (California) to 14.6% (Australia). The prevalence
of PTB ranging from 3.9% (Finland) to 8.6% (California); spontaneous PTB was between 2.9%
and 4.0% for all countries; and SGA was similar for all countries ranging from 6.7% (Norway)
to 8.0% (Australia) (S2 Table).
Table 1. Maternal characteristics at study entry (first birth in the included cohort)� for the within-women analysis (n = 1,233,688).
Characteristics Australia Finland Norway California
N (%) N (%) N (%) N (%)
Total women 306,639 202,252 219,770 505,027
Parity��
1 273,911 (89.3) 186,615 (92.3) 205,117 (93.4) 495,390 (98.1)
2 20,649 (6.7) 9,352 (4.6) 10,851 (4.9) 9,222 (1.8)
�3 12,079 (3.9) 6,285 (3.10) 3,802 (1.7) 415 (0.1)
Maternal age (years)
<20 12,764 (4.2) 2,749 (1.4) 2,194 (1.0) 50,034(9.9)
20–24 75,219 (24.5) 48,734 (24.1) 51,674 (23.5) 177,492 (35.2)
25–29 109,210 (35.6) 86,098 (42.6) 98,248 (44.7) 148,185 (20.3)
30–34 85,271 (27.8) 52,316 (25.9) 56,904 (25.9) 100,803 (20.0)
35–39 22,686 (7.4) 11,442 (5.7) 10,215 (4.65) 26,882 (5.3)
�40 1,489 (0.5) 913 (0.5) 535 (0.2) 1,631 (0.3)
Birth year
1980–1989 29,804 (9.7) 9,400 (4.6) 54,220 (24.7) -
1990–1999 79,256 (25.8) 87,752 (43.4) 79,037 (36.0) 199,063 (30.5)
2000–2009 147,576 (48.1) 75,221 (37.2) 70,198 (31.9) 290,640 (57.5)
2010 or later 50,003 (16.3) 29,879 (14.8) 16,315 (7.4) 15,324 (3.0)
Socioeconomic index for areas (quintile)
Lowest 71,259 (23.2) N/A N/A N/A
Low 62,479 (20.4) N/A N/A N/A
Middle 56,814 (18.5) N/A N/A N/A
High 52,143 (17.0) N/A N/A N/A
Highest 47,595 (15.5) N/A N/A N/A
Other/unknown/missing 16,349 (5.3) N/A N/A N/A
Maternal occupation
Upper-white collar worker N/A 22,675 (13.9) N/A N/A
Lower-white collar worker N/A 74,147 (36.7) N/A N/A
Blue collar worker N/A 32,702 (16.2) N/A N/A
Other or unknown N/A 67,728 (33.5) N/A N/A
Highest level of maternal education
Some high school or less N/A N/A N/A 99,696 (19.7)
High school diploma/Equivalent N/A N/A N/A 169,195 (33.5)
Some college N/A N/A N/A 120,038 (23.8)
College graduate or more N/A N/A N/A 109,357 (21.7)
Missing N/A N/A N/A 6,741 (1.3)
Number of IPIs
2 220,175 (71.8) 144,141(71.3) 177,636 (80.8) 385,449 (76.3)
�3 86,464 (28.2) 58,111 (28.7) 42,134 (19.2) 119,578 (23.7)
�Study entry is defined as the earliest birth (second birth) at which the women appeared within the included cohort during the study period.
��Women parity at the birth when entering to the cohort (i.e the second birth after interval). IPI -_Interpregnancy intervals. N/A—data were not available in these
countries.
https://doi.org/10.1371/journal.pone.0255000.t001
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The between-women analyses showed elevated odds of PTB ranging from 1.42 (California)
to 2.06 (Norway); spontaneous PTB ranging from 1.67 (California) to 2.04 (Norway); and SGA
ranging from 1.07 (Finland) to 1.42 (California) for short IPIs of<6 months compared to IPI
of 18–23 months in all countries. For long IPIs, the odds of PTB, sPTB, and SGA from
between-women analyses were elevated for all countries. In the within-women analyses, com-
pared to an IPI of 18–23 months, there were elevated odds of PTB after IPIs of<6 months and
6–11 months in Australia and California, but no association for Finland and Norway. The
odds of spontaneous PTB after an IPI <6 months were elevated for all countries, ranging from
1.21 (Norway) to 1.66 (Australia). Except for California, the odds of SGA were reduced in Aus-
tralia, Finland and Norway after an IPI of<6 months compared with an IPI of 18–23 months.
For long IPIs, the odds of PTB, sPTB, and SGA from within-women analyses were elevated for
all countries (Table 3).
Pooled analyses
Pooled adjusted between-women analyses indicated association between IPI and adverse birth
outcomes. Elevated odds of all adverse outcomes were observed for short IPIs (<6 months and
6–11 months) and long IPI categories (24–59 months, 60–119 months, and�120 months)
(S2–S4 Figs).
Pooled adjusted within-women analyses indicated no or weak association between IPIs of
<6 months (aOR 1.08, 95% CI: 0.99, 1.18) and PTB, compared with 18–23 months of IPI (Fig
1). Odds of spontaneous PTB were elevated for IPIs <6 months (aOR = 1.38, 95% CI: 1.21,
1.57) (Fig 2). For SGA, there was no observed association for IPIs of<6 months (aOR = 0.99,
95% CI: 0.81, 1.19) (Fig 3). The pooled estimate for long IPI categories of 60–119 months and
�120 months were consistently associated with elevated odds of all adverse birth outcomes
(Figs 1–3).
For between-women and within-women analyses, the direction of association between IPI
and the adverse birth outcomes was mostly consistent between countries, except for IPI <6
months for PTB and SGA in the within-women analyses (Figs 1 and 3). The magnitude of
associations varied across countries for both between-women and within-women analyses.
Heterogeneity between countries (I2) generally exceeded 50% for all outcomes (Figs 1–3, S2–
S4 Figs).
Sensitivity analyses
Additional adjustment for SES resulted in negligible change to the results (S3 Table). Restric-
tion to live births, also had negligible influence on the observed associations for most countries
Table 2. Interpregnancy interval distribution for births in within-women analyses across the four countries (n = 2,905,703).
IPI category (months) Australia N (%) Finland N (%) Norway N (%) California
N (%)
Total N (%)
<6 54,847 (7.4) 30495 (5.6) 18,617 (3.8) 91,473 (7.9) 195,432 (6.7)
6–11 132,930 (18.0) 94,415 (18.6) 58,987 (12.0) 172,445 (14.8) 458,778 (15.8)
12–17 144,015 (19.5) 94,069 (18.5) 75,168 (15.2) 185,782 (16.0) 499,035 (17.2)
18–23 107,880 (14.6) 66,998 (13.2) 66,934 (13.6) 150,103 (12.9) 391,916 (13.5)
24–59 230,998 (31.3) 159685 (31.4) 194,292 (39.4) 414,553 (35.6) 999,529 (34.3)
60–119 60,090 (8.1) 54622 (10.7) 67,966 (13.8) 134,038 (11.5) 316,723 (10.9)
�120 8,337 (1.1) 8749 (1.7) 11,157 (2.3) 16,058 (1.4) 44,301 (1.5)
�Numbers in brackets are column percentages for IPI categories in each country
https://doi.org/10.1371/journal.pone.0255000.t002
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Table 3. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) between interpregnancy interval and adverse birth outcomes among births in between-
women� and within-women�� analyses across the four countries.
Outcome by country Interpregnancy interval
<6 months 6–11 months 12–17 months 18–23 months 24–59 months 60–119 months �120 months
PTB aOR (95% CI)
Australia
Between-women 1.68 (1.63, 1.73) 1.13 (1.10, 1.16) 0.99 (0.97, 1.02) Ref 1.16 (1.13, 1.19) 1.59 (1.55, 1.64) 2.14 (2.03, 2.27)
Within-women 1.22 (1.15, 1.29) 1.08 (1.03, 1.14) 1.00 (0.95, 1.05) Ref 1.06 (1.02, 1.11) 1.35 (1.27, 1.43) 1.71 (1.52, 1.92)
Finland
Between-women 1.62 (1.53, 1.70) 1.06 (1.01, 1.10) 0.99 (0.95, 1.10) Ref 1.12 (1.08, 1.16) 1.41 (1.35, 1.47) 1.73 (1.61, 1.86)
Within-women 1.00 (0.91, 1.09) 1.02 (0.95, 1.10) 0.95 (0.88, 1.02) Ref 1.00 (0.94, 1.07) 1.26 (1.16, 1.37 1.67 (1.44, 1.95)
Norway
Between-women 2.06 (1.96, 2.17) 1.17 (1.12, 1.22) 1.02 (0.98, 1.06) Ref 1.11 (1.08, 1.15) 1.51 (1.45, 1.57) 1.91 (1.82, 2.02)
Within-women 0.97 (0.88, 1.06) 1.01 (0.93, 1.09) 1.03 (0.96, 1.12) Ref 1.08 (1.02, 1.15) 1.38 (1.29, 1.49) 1.71 (1.51, 1.93)
California
Between-women 1.42 (1.39, 1.45) 1.16 (1.14, 1.18) 1.06 (1.05, 1.08) Ref 1.12 (1.10, 1.14) 1.41 (1.39, 1.44) 1.82 (1.76, 1.88)
Within-women 1.13 (1.09, 1.18) 1.10 (1.06,1.14) 1.07 (1.03,1.11) Ref 1.00(0.97, 1.03) 1.17 (1.13, 1.22) 1.42 (1.31, 1.54)
Spontaneous PTB
Australia
Between-women 1.93 (1.85, 2.01) 1.22 (1.18, 1.27) 1.03 (0.99, 1.07) Ref 1.13 (1.10, 1.17) 1.56 (1.50, 1.63) 1.99 (1.84, 2.16)
Within-women 1.66 (1.54, 1.79) 1.30 (1.22, 1.39) 1.07 (1.00, 1.14) Ref 0.96 (0.90, 1.02) 1.10 (1.02, 1.19) 1.28 (1.09, 1.51)
Finland
Between-women 1.77 (1.66, 1.88) 1.14 (1.09, 1.20) 1.04 (0.99, 1.09) Ref 1.15 (1.10, 1.20) 1.45 (1.37, 1.52) 1.76 (1.62, 1.92)
Within-women 1.32 (1.19, 1.46) 1.22 (1.12, 1.34) 1.04 (0.96, 1.14) Ref 1.05 (0.96, 1.13) 1.35 (1.22, 1.49) 1.77 (1.47, 2.13)
Norway
Between-women 2.04 (1.92, 2.18) 1.22 (1.16, 1.28) 1.04 (0.99, 1.09) Ref 1.06 (1.02, 1.10) 1.40 (1.34, 1.47) 1.78 (1.64, 1.90)
Within-women 1.21 (1.08, 1.36) 1.10 (1.00, 1.21) 1.04 (0.95, 1.14) Ref 0.93 (0.86, 1.01) 1.12 (1.02, 1.23) 1.29 (1.09, 1.51)
California
Between-women 1.67 (1.62, 1.72) 1.15 (1.12, 1.18) 1.03 (1.00, 1.06) Ref 1.15 (1.12, 1.17) 1.52 (1.48, 1.56) 1.96 (1.88, 2.05)
Within-women 1.34 (1.26, 1.42) 1.12 (1.06, 1.18) 1.06 (1.00, 1.13) Ref 1.05 (1.00, 1.10) 1.35 (1.27, 1.43) 1.65 (1.47, 1.86)
SGA
Australia
Between-women 1.10 (1.07, 1.13) 0.99 (0.97, 1.01) 0.98 (0.96,1.01) Ref 1.18 (1.15, 1.20) 1.65 (1.61, 1.69) 2.08 (1.98, 2.19)
Within-women 0.94 (0.87, 0.99) 0.99 (0.95, 1.04) 1.03 (0.99,1.08) Ref 1.04 (1.00, 1.09) 1.24 (1.17, 1.31) 1.58 (1.40, 1.78)
Finland
Between-women 1.07 (1.03, 1.12) 0.95 (0.92, 0.98) 0.98 (0.95, 1.01) Ref 1.09 (1.06, 1.12) 1.35 (1.31, 1.40) 1.72 (1.63, 1.81)
Within-women 0.89 (0.82, 0.96) 0.99 (93, 1.05) 1.00 (0.95, 1.07) Ref 1.08 (1.02, 1.13) 1.24 (1.16, 1.32) 1.80 (1.59, 2.03)
Norway
Between-women 1.28 (1.22, 1.35) 1.08 (1.05, 1.12) 1.02 (0.99, 1.05) Ref 1.11 (1.08, 1.14) 1.42 (1.37, 1.46) 1.83 (1.75, 1.92)
Within-women 0.88 (0.81, 0.97) 0.98 (0.91, 1.05) 0.97 (0.91, 1.03) Ref 1.05 (1.00, 1.11) 1.26 (1.18, 1.34) 1.63 (1.45, 1.82)
California
Between-women 1.42 (1.39, 1.46) 1.08 (1.06, 1.10) 1.00 (0.98, 1.02) Ref 1.13 (1.11, 1.15) 1.37 (1.34, 1.40) 1.64 (1.59, 1.70)
Within-women 1.26 (1.20, 1.31) 1.05 (1.01, 1.09) 1.00 (0.96, 1.04) Ref 1.03 (1.00, 1.07) 1.17 (1.12, 1.22) 1.52 (1.39, 1.67)
aOR—adjusted odds ratio. CI—confidence interval. IPI—interpregnancy interval. PTB—preterm birth. SGA—small for gestational age.
�Odds ratios calculated using between-women analyses for women with�2 births/�1 IPI after prognostic score adjustment for maternal age, parity, and year of birth.
��Odds ratios calculated using within-women analyses for women with�3 births/�2 IPIs after prognostic score adjustment for maternal age, parity, and year of birth
https://doi.org/10.1371/journal.pone.0255000.t003
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(S4 Table), and an increase in the odds of PTB in Norway (0.97 to 1.32) for IPI<6 months.
The results of the between-women analyses restricted to women with at least two IPIs (at least
three births) were consistently similar with the results of between-women analyses for women
with at least one IPI (S5 Table). Moreover, our additional analysis restricting our cohorts in
Australia and Norway to the first three births (parity 0, 1, and 2) for accounting the inclusion
of births from women in the higher-order parity did not significantly change the results (S6
Table). Our analysis restricting births from 1990 onwards in Norway, when ultrasound has
been widely used to precisely estimate gestational ages, had negligible impact on our results
(S7 Table).
Fig 1. Adjusted odds ratios of within-women analysis for the association between interpregnancy interval and preterm
birth as compared to 18–23 months interpregnancy interval by country. IPI—Interpregnancy interval. �Adjusted Odds ratios
(aOR) and corresponding 95% confidence intervals, adjusted for maternal age, parity, and birth year; the reference IPI category
is 18–23 months. ��Weights are derived from inverse-variance.
https://doi.org/10.1371/journal.pone.0255000.g001
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Discussion
This international cohort study of nearly five and half million births indicated associations
between both short and long IPIs and adverse birth outcomes in four high-income countries,
when pregnancies to different women were compared. After comparing pregnancy outcomes
after IPIs within the same women with at least three pregnancies, we observed smaller odds
ratios, but consistently elevated odds of all outcomes (PTB, spontaneous PTB, and SGA) for
long IPIs. Associations with short IPIs were limited to the spontaneous PTB outcome.
Fig 2. Adjusted odds ratios for within-women analysis for the association between interpregnancy interval and spontaneous
preterm birth as compared to 18–23 months of interpregnancy interval by country. IPI—interpregnancy interval. �Adjusted Odds
ratios (aOR) and corresponding 95% confidence intervals, adjusted for maternal age, parity, and birth year; the reference IPI category is
18–23 months. ��Weights are derived from inverse-variance.
https://doi.org/10.1371/journal.pone.0255000.g002
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Consistent with previous literature, results from our between-women analyses indicated
elevated odds of adverse birth outcomes for both short and long IPIs [1, 8, 10, 17, 35]. Esti-
mates were smaller in within-women analyses, indicating bias away from the null attributed
from confounders that vary between-women.
Associations between IPI and adverse birth outcomes have been investigated by comparing
pregnancies to the same women in two independent cohorts from Canada and Sweden [21,
22]. Our finding of a lack of association between short IPIs and SGA and PTB was consistent
with the results from the Canadian study [21]. However, the Canadian study reported a
reduced odds ratio (0.85) for PTB. The Swedish study reported a slightly elevated odds ratio
(1.23) of PTB for short IPI [22]. In our study, evidence of associations were less apparent for
overall PTB than for spontaneous PTB. Medical intervention shortens the pregnancy length
[36] and it is possible that IPI is not as strongly associated with the clinical indications for PTB
as it is with spontaneous onset of preterm labour. This hypothesis is supported by results from
other between-women studies in Canada and California [1, 23], that found greater odds of a
Fig 3. Adjusted odds ratios for the within-women analysis for the association between interpregnancy interval
and small-for-gestational age birth as compared to 18–23 months of interpregnancy interval by country. IPI—
interpregnancy interval. �Adjusted Odds ratios (aOR) and corresponding 95% confidence intervals, adjusted for
maternal age, parity, and birth year; the reference IPI category is 18–23 months. ��Weights are derived from inverse-
variance.
https://doi.org/10.1371/journal.pone.0255000.g003
PLOS ONE Interpregnancy intervals and adverse birth outcomes
PLOS ONE | https://doi.org/10.1371/journal.pone.0255000 July 19, 2021 10 / 17
spontaneous PTB (2.41 for Canada, 1.81 for California) than the odds for medically indicated
PTB (1.88 for Canada, 1.35 for California).
We observed elevated odds of adverse birth outcomes for long IPIs for our cohort. While
the study from Sweden showed similar results with long IPIs [22], the Canadian study did not
[21]. Despite consistent evidence there are currently no recommendations to limit long IPI.
The explanation for the association between IPI and adverse birth outcomes is not well-
understood. Given the lack of observed associations between overall PTB and SGA with short
IPI, our findings do not provide support for the maternal depletion hypothesis (nutritional
depletion) that has been previously suggested, at least in low- and middle-income countries
[11, 37, 38]. A potential mechanism for the association between short IPI and spontaneous
PTB may be the failure of uterine contraction associated chemicals/proteins, such as G protein
coupled receptors, to return back to pre-pregnancy levels, which could predispose women of
short IPI for preterm onset of labour [3, 39]. Short IPIs also do not permit adequate time to
recover from infections that cause inflammatory disease such as endometritis [40], and leave
less time for the uterine incision to heal after caesarean section.[37, 41] Short IPIs may leave
women with insufficient time to lose excess weight gained during pregnancy. Maternal over-
weight or obesity may result in increased risk of inflammatory up-regulation [42], and
increased levels of inflammatory proteins (cytokines) may lead to cervical ripening and cause
weakening of the membranes and preterm myometrial contractions through prostaglandin
activation [43]. Unfortunately, owing to the administrative nature of study data these and
other potential mechanistic hypotheses could not be investigated.
Our observation of increased risk of adverse birth outcomes after long IPIs might be
explained by the potential gradual decline in uterine adaptation over time, such as changes to
uterine blood flow that can result in regression back to a primigravida state [10]. A previous
study observed that outcomes of births conceived after a long IPI are similar to perinatal out-
comes of births born to women who are pregnant for the first time [10]. In addition, the
increased risk of adverse birth outcomes after a long IPI may be due to underlying causes such
as sexually transmitted infections or maternal chronic illnesses that lead to both secondary
sub-fertility and adverse perinatal outcomes [35, 44]. While partner change has previously
been suggested as a potential factor explaining the association between IPI and adverse preg-
nancy outcomes [45], a recent study in Western Australia indicated that partner changes
between pregnancies did not influence the association between IPI and risk of preeclampsia
[46].
We could not analytically explore a range of time-varying potential covariates such as pre-
pregnancy body mass index, diet during pregnancy, maternal medical conditions and fertility
treatment due to lack of complete information in the cohorts across countries. Notably,
women who conceive quickly after childbirth might be relatively healthy and relatively more
fertile than women who conceive later and therefore less prone to adverse birth outcomes [30].
Fertility treatment is associated with adverse birth outcomes [47, 48] and longer IPIs due to
the requirement of a longer period of time to conception in sub-fertile couples [49]. Although
we expect that only small proportion of women (1–4%) received fertility treatment in the
cohort periods of this study [50–52], the uptake of reproductive technology is rapidly increas-
ing in some countries [53] which may suggest that future studies need to account for assisted
reproductive technology. As the primary design for this study was within-women (matched)
analysis, conditioning on the outcome (i.e adverse birth outcomes) prior to the interval would
introduce potential bias with estimated effect sizes because for those women with two intervals,
the outcome of the second pregnancy would also be an effect modifier of the effect of IPI on
the third pregnancy. However, a previous analysis using between-women analysis suggested
that previous PTB may modify the effect of IPI on PTB in the subsequent pregnancies [54].
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Our study also did not adjust for maternal ethnicity/race due to lack of complete information
across cohorts and it is possible that the between-women results are prone to confounding by
these variables. Since maternal ethnicity/race would not change between pregnancies, our
within-women analysis will account this time-invariant confounder and therefore not adjust-
ing for maternal ethnicity/race would not significantly change within-women results. None-
theless, generalisability to other study populations might still be affected by within-country
heterogeneity in race/ethnicity. However, a Californian study reported that the effect of short
IPI on the risks of PTB did not substantially differ between non-Hispanic White and non-His-
panic Black women [2]. Given the within women analysis included small number of women
with at least two IPIs (three or more births), these women may represent highly selected cohort
of women and hence may not be generalisable to the general population. However, the results
of the between-women analyses comprising these women were consistent with the results
from the between-women analyses comprising at least one IPI (two or more births) over the
study period suggesting it is unlikely that our results are necessarily reflective of differences in
the two cohorts of women.
Undetected pregnancy loss (miscarriage, induced abortion and stillbirth) inflates IPI and is
a marker for adverse birth outcomes in subsequent pregnancies [55]. Unlike previous studies
that restricted analyses to consecutive live births [20, 22, 56], we included both live births and
stillbirths, but could not account for pregnancy loss before 22 weeks. The associations between
IPI and preterm birth might differ by presentation based on timing of delivery (extreme PTB
(<28 weeks), very PTB (28–31 weeks), moderate PTB (32–37 weeks)) [3], however, the scope
of this study was limited to separately investigate the association between IPI and PTB classi-
fied by clinical presentation (spontaneous and overall PTB).
Although there was substantial heterogeneity in the magnitude of the effects, the direction
of associations was generally consistent. Part of the heterogeneity in the magnitude of results
could be due to the difference in the characteristics of the population. For example, unlike
Australia and California, the population in Norway and Finland represent relatively ethnically
homogenous populations. An alternative explanation for the large observed heterogeneity (I2)
is that most of the results were similar between countries, but I2 appears large because within-
study variability was small, which is a natural consequence of large registry-based studies that
benefit from large sample sizes [17, 57]. To accommodate potential heterogeneity, we con-
ducted random effects meta-analysis.
In conclusion, our international study from four high-income countries indicates insuffi-
cient evidence for association between short IPI and adverse birth outcomes, except for a
slightly elevated odds of spontaneous PTB for IPIs <6 months. We found consistently elevated
odds of adverse birth outcomes for births following long IPIs. Previous recommendations for
parents to wait at least 24 months may be unnecessarily long in high-income countries, while
recommendations regarding long IPI are required.
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